• Cerus Corp CERS.OQ reported a quarterly adjusted loss of 3 cents​​ per share for the quarter ended June 30, identical to the same quarter last year. The mean expectation of four analysts for the quarter was for a loss of 3 cents per share. Wall Street expected results to range from -4 cents to -1 cents per share.

• Revenue rose 16.3% to $52.45 million from a year ago; analysts expected $54.38 million.

• Cerus Corp's reported EPS for the quarter was a loss of 3 cents​.

• The company reported a quarterly loss of $5.71 million.

• Cerus Corp shares had fallen by 7.8% this quarter and lost 15.6% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 8.3% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

• Wall Street's median 12-month price target for Cerus Corp is $5.00, about 74% above its last closing price of $1.30

This summary was machine generated from LSEG data August 5 at 09:00 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)